Pacer Advisors
COGT icon

Pacer Advisors’s Cogent Biosciences COGT Stock Holding History

Pacer Advisors’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57K Buy
+1,469
New +$51.4K ﹤0.01% 2005
2024
Q3 		– Sell
-1,046
Closed -$8.82K – 2590
2024
Q2 		$8.82K Sell
1,046
-2,233
-68% -$16.9K ﹤0.01% 3568
2024
Q1 		$22K Buy
+3,279
New +$20.3K ﹤0.01% 3427

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Pacer Advisors's COGT Position: Q2 2026 in Review

Pacer Advisors opened a new position in Cogent Biosciences (COGT) in Q2 2026: 1,469 shares worth $57K. The stake represents ﹤0.01% of the portfolio and ranks #2005 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in COGT as recently as Q2 2024.

Pacer Advisors first reported a position in COGT in Q1 2024 and has held it in 3 quarters since. 324 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Pacer Advisors held 1,469 shares of Cogent Biosciences worth $57K as of Q2 2026.
  • Cogent Biosciences was a new Pacer Advisors position in Q2 2026.
  • Cogent Biosciences made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #2005 holding.
  • Pacer Advisors first reported a position in Cogent Biosciences in Q1 2024 and has held it in 3 quarters since.
  • 324 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.